Explore
Trendline
Caris Life Sciences Seeks New York State Approval for Blood-Based Molecular Profiling Test
Caris Life Sciences Seeks New York State Approval for Blood-Based Molecular Profiling Test
Read More
Trendline
Caris Life Sciences Reports Significant Revenue Growth in First Quarter 2026
Caris Life Sciences Reports Significant Revenue Growth in First Quarter 2026
Read More
Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Read More
Trendline
Myomo Reports Q1 2026 Financial Results with Increased Revenue and Narrowed Loss
Myomo Reports Q1 2026 Financial Results with Increased Revenue and Narrowed Loss
Read More
Trendline
Quantum-Si Reports First Quarter 2026 Financial Results and Advances Proteus Development
Quantum-Si Reports First Quarter 2026 Financial Results and Advances Proteus Development
Read More
Trendline
Charles River Laboratories Reports Q1 2026 Revenue Growth Amid Divestitures
Charles River Laboratories Reports Q1 2026 Revenue Growth Amid Divestitures
Read More
Trendline
Tandem Diabetes Care Reports Record Q1 2026 Financial Results and Strategic Advances
Tandem Diabetes Care Reports Record Q1 2026 Financial Results and Strategic Advances
Read More
Trendline
Quantum-Si Announces First Quarter 2026 Financial Results and Proteus Development Milestones
Quantum-Si Announces First Quarter 2026 Financial Results and Proteus Development Milestones
Read More
Trendline
Tandem Diabetes Care Reports Strong First Quarter 2026 Financial Results
Tandem Diabetes Care Reports Strong First Quarter 2026 Financial Results
Read More
Trendline
Personalis Secures Medicare Coverage for Lung Cancer, Reports Q1 Financial Results
Personalis Secures Medicare Coverage for Lung Cancer, Reports Q1 Financial Results
Read More
Trendline
Aurinia Pharmaceuticals Reports Strong Q1 2026 Financial Results and Reaffirms Revenue Guidance
Aurinia Pharmaceuticals Reports Strong Q1 2026 Financial Results and Reaffirms Revenue Guidance
Read More
Trendline
Intellia Therapeutics Advances CRISPR Gene Editing with FDA Application for Hereditary Angioedema Treatment
Intellia Therapeutics Advances CRISPR Gene Editing with FDA Application for Hereditary Angioedema Treatment
Read More
